Navigation Links
Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012
Date:4/1/2012

bsite: http://www.lifetechnologies.com.

Life Technologies' Safe Harbor Statement

This press release includes forward-looking statements about Life Technologies' anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.

(Logo: http://photos.prnewswire.com/prnh/20110216/MM49339LOGO )

Life Technologies Contact
Suzanne Clancy
760-602-4545
760-717-8294 (mobile)
suzanne.clancy@lifetech.com

 


'/>"/>
SOURCE Life Technologies Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Cobalt Technologies Hits Key Commercial Milestone with Pretreatment Process Demonstration
2. Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference
3. Updated: Life Technologies Announces Fourth Quarter and Fiscal Year 2011 Results
4. BioSpecifics Technologies Corp. Announces Presentations at Two Upcoming Investor Conferences in March
5. Life Technologies to Present at Barclays Capital Global Healthcare Conference
6. Medisafe 1 Technologies to Start the $1MM Stock Repurchase Program of 10MM Shares up to 10 Cents a Share
7. Spherix to Present at the LHA Life Sciences & Medical Technologies Virtual Conference on February 16
8. BioStorage Technologies to Host Global Sample Management Workshop at Partnerships in Clinical Trials
9. UV Flu Technologies Continues Aggressive Program to Pay off Convertible Debt
10. Generex Announces Patent Award for its Core Vaccine Technologies in Japan
11. FirstMark to Exhibit at Cardiovascular Research Technologies (CRT) 2012 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Colo. , Jan. 23, 2015  Array BioPharma Inc. ... has reached a definitive agreement with Novartis Pharma AG ... inhibitor currently in Phase 3 development.  This agreement is conditional ... GlaxoSmithKline PLC (GSK) on April 22, 2014, which are expected ...
(Date:1/22/2015)... Eckert & Ziegler Vitalea Science (EZVS), ... to the pharmaceutical and biotech industry, has announced that ... the position of Director of Science & Technology. , ... experience in drug metabolism and bioanalysis to EZVS in ...
(Date:1/22/2015)... today announces the firm brokered a long-term lease totaling 202,492 ... company, at Two Ledgemont Center in Lexington, Massachusetts ... and Brian Cohen , senior vice president, represented Shire ... Hayden Ave. Photo - http://photos.prnewswire.com/prnh/20150122/170765 ...
(Date:1/22/2015)... today announces the firm brokered a long-term lease totaling 202,492 ... company, at Two Ledgemont Center in Lexington, Massachusetts ... and Brian Cohen , senior vice president, represented Shire ... Hayden Ave. Photo - http://photos.prnewswire.com/prnh/20150122/170765 ...
Breaking Biology Technology:Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 2Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 3Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 4Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 5Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 6Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 7Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 2Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 3Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Transwestern?RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2
... April 5, 2012  Albright Stonebridge Group (ASG), a ... four new senior advisors – Hakan Akbas, Steven ... focus on leading ASG,s commercial activities and advising ... will support clients of ASG,s Brazil practice as ...
... 2012 BIND Biosciences, a clinical-stage biopharmaceutical company developing ... therapeutics called AccurinsTM, that are capable of up to ... has published preclinical and clinical data in Science ... and successful clinical translation of BIND-014, the first targeted ...
... (March X, 2012) framergyTM, which was recently accepted ... up with engineers from the Space Alliance Technology Outreach ... initiative designed to speed the transfer of knowledge and ... to propel commercialization of its proprietary energy-storing Metal Organic ...
Cached Biology Technology:Experts Strengthen Albright Stonebridge Group's Global Reach 2Experts Strengthen Albright Stonebridge Group's Global Reach 3First targeted and programmable nanomedicine to show clinical antitumor effects published 2First targeted and programmable nanomedicine to show clinical antitumor effects published 3First targeted and programmable nanomedicine to show clinical antitumor effects published 4framergyTM to partner with the Space Alliance Technology Outreach Program 2framergyTM to partner with the Space Alliance Technology Outreach Program 3
(Date:12/22/2014)... and Markets ( http://www.researchandmarkets.com/research/fx4bg3/the_global ) has ... Watermarking and Fingerprinting Markets" report to their ... This insight provides an overview of ... Watermarking aims to control and monitor piracy by ...
(Date:12/19/2014)... LAS VEGAS , Dec. 18, 2014   LaunchKey ... built for the post-password and Internet of Things era, ... seed funding. The venture round was led by Metamorphic ... Capital, Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey has ...
(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ( ... "Global Chemical Sensor Market 2015-2019" report to their ... One major trend upcoming in this market is ... Chemical sensors help in recording of patient data for ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... Alberta researchers have developed a new web-based tool to ... for injured workers, helping them feel better and get ... of artificial intelligence called machine learning to analyze injury ... create a tool that recommends an appropriate course of ...
... Jeff Gore, Ph.D. , an assistant professor in physics at Massachusetts Institute ... Gore is studying how game theory can be applied to bacterial evolution, ... ... Inspired by Richard Dawkin,s The Selfish Gene, Gore is interested in the ...
... a simple "ouch" to the chronic and excruciating, has been ... a promising step toward studying pain in action. In a ... Society , scientists describe the development of a new technique, ... ways to relieve pain and monitor healing. Sandip Biswal, ...
Cached Biology News:Online tool aids clinicians' efforts to treat injured workers 2
CHIMAERIC HUMAN IgA2 ANTI NP...
ANTI NO-TRYPTOPHAN CONJUGATE...
... The Captivate magnetic ... can be used in conjunction ... (C-21473, C-21474, C-21476) or other ... with most 96-well microplates. Cell ...
Protein Phosphorylation...
Biology Products: